Testing effectiveness (Phase 2)Active Not RecruitingNCT06009861
What this trial is testing
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Who this might be right for
Oral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Peking University Hospital of Stomatology 110